<DOC>
	<DOCNO>NCT00626782</DOCNO>
	<brief_summary>Does new add ( adjunctive ) therapy use glaucoma surgery improve success trabeculectomy ? Ranibizumab may offer benefit similar mitomycin C prevent epi-scleral fibrosis avoid well know complication mytomycin C include late bleb leak , hypotony infection .</brief_summary>
	<brief_title>Lucentis Versus Mitomycin C During Glaucoma Surgery</brief_title>
	<detailed_description>This open-label , single center trial two arm patient undergo guard filtration surgery control glaucoma . The control consist patient randomly assign receive inter-operative mitomycin C 0.4 mg/ml apply standard fashion soak pledget insert sub-tenon 's space surgery . The study arm consist patient randomly assign receive sub-tenon injection Ranibizumab 0.5 mg/0.05mL 30 gauge needle tuberculin syringe termination surgery . No mitomycin C apply . Post operative follow-up consist minimum 6 visit one year period .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>18 yrs old patient require first time glaucoma filter surgery phakic pseudophakic must provide write informed consent comply study assignment Pregnant , lactation premenopausal woman use adequate contraception . Previous glaucoma surgery , tube shunt surgery , par plana vitrectomy , scleral buckle , penetrate keratoplasty . Abnormality prevent reliable applanation tonometry eye . Current infection inflammation either eye . Enrolled another investigational study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>glucoma filtering surgery</keyword>
	<keyword>ranibizumab</keyword>
	<keyword>mitomycin C</keyword>
	<keyword>patient require first time glaucoma filtering surgery</keyword>
</DOC>